English
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
Targeted NGS Seen as Best When Screening for SMA and Its Carriers
Targeted next generation sequencing (NGS) — a powerful genetic method that can identify mutations in several genes simultaneously — is superior to two commonly used genetic tests for the screening of spinal muscular atrophy (SMA), a study shows.
These findings highlight targeted NGS as a reliable and promising approach for SMA screening, particularly in identifying disease carriers, the researchers noted. The study, “Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene,” was published in the journal Scientific Reports.
Nearly all SMA cases are caused by the complete loss of exon 7 in both copies of the SMN1 gene — one inherited from the mother and one from the father. Exons are the sections of a gene that contain the information to generate proteins.
BookmarkRelated Content
-
Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening AssaySpinal muscular atrophy (SMA) is an auto...
-
Integrating Newborn Screening for Spinal Muscular Atrophy Into Health Care Systems: An Australian Pilot ProgrammeAim: This study dynamically designed, ev...
-
Spinal Muscular Atrophy: From Rags to RichesThe aim of this paper is to provide a sh...
-
A Novel CARM1-HuR Axis Involved in Muscle Differentiation and Plasticity Misregulated in Spinal Muscular AtrophySpinal muscular atrophy (SMA) is charact...
-
Sofia’s Story – Johns Hopkin’sOn the morning of Friday, Aug. 23, 2019,...
-
Developing Motor Neurons in SMA Show Altered Protein ProductionMotor neurons derived from people with s...
-
Carrier Screening for Genetic ConditionsCarrier screening is a term used to desc...
Powered by
In partnership with
